A bidirectional interaction between the circadian network and effector mechanisms of immunity brings on a proper working of both systems. In the present study, we used Hodgkin lymphoma (HL) as an experimental model for a type of cancer involving cells of the immune system. We identified this cancer type among haematological malignancies has having a strong differential expression of coreclock elements. Taking advantage of bioinformatics analyses and experimental procedures carried out in III-and IV-stage HL cells, and lymphoblastoid B cells, we explored this interplay and bear out diverse interacting partners of both systems. In particular, we assembled a wide-ranging network of clock-immune-related genes and pinpointed TNF as a crucial intermediary player. A robust circadian clock hallmarked III-stage lymphoma cells, differently from IV-stage HL cells, which do not harbour a properly functioning clockwork. TNF and circadian gene modulation impacted on clock genes expression and triggered phenotypic changes in lymphoma cells, suggesting a crucial involvement of core-clock elements and TNF in the physiopathological mechanisms hastening malignancy. Our results move forward our understanding of the putative role of the core-clock and TNF in the pathobiology of Hodgkin lymphoma, and highlight their influence in cellular proliferation and migration in lymphatic cancers.
SCIenTIFIC RepoRTS | (2018) 8:11474 | DOI:10.1038/s41598-018-29847-z Subsequently, we carried out an analysis for enriched elements present in the pathway "Circadian rhythms related genes" in the WikiPathway data base. This list was mostly enriched in comparisons between Hodgkin lymphoma (HL), a lymphoproliferative disease characterized by the presence of Hodgkin and Reed-Sternberg cells, and the other haematological cancers with 37 ± 4 (mean, SEM) differentially expressed genes within the defined pathway ( Fig. S2A-D) . This points to a severe dysregulation of circadian clock elements in HL, as compared to other tumours of the hematopoietic and immune system, which made this particular cancer type an interesting model system for our subsequent analysis.
The Hodgkin lymphoma cell line HD-MY-Z shows robust oscillations in gene expression.
We choose the HL cell lines HD-MY-Z (HL stage III b) and L-1236 (HL stage IV) to model disease progression and a lymphoblastoid B-cell line (LCL-HO) (established by EBV transformation, considering the recognized pathogenetic role for EBV infection in HL). There are relevant clinical differences between the different stages in Hodgkin lymphoma (HL). In stage III HL, the disease involves lymph node areas on both sides of the diaphragm or lymph nodes above the diaphragm and in the spleen. In stage IV HL, the disease has spread widely into at least one organ outside of the lymph system. In the presence of additional symptoms e.g. loss of more than 10% of body weight, fever and/or drenching night sweats, the letter B is added to the stage 34 .
The three cell types exhibit different oscillatory patterns of core-clock gene expression as depicted by non-invasive long-term bioluminescence recording and expression of the core-clock genes, Bmal1 and Per2 ( Fig. 2E-G) . LCL-HO (T = 29.33 ± 1.27 h; n = 3; mean and SEM) and L-1236 (T = 32.61 ± 2.35 h; n = 3; mean and SEM) showed weak oscillations for both genes with prolonged periods (representative results in Fig. 2E,G) , thus suggesting a disruption in the circadian clock machinery in the mentioned cell lines. Furthermore, the antiphasic oscillation pattern between Bmal1 and Per2 is partially lost for these cell lines. In contrast, the HL cell line HD-MY-Z showed a strong circadian clock with robust (T = 23.51 ± 0.055 h; n = 3; mean and SEM; representative results in Fig. 2F ) and antiphasic oscillations of Bmal1 and Per2. We subsequently focused on HD-MY-Z cells as a HL model and the EBV growth-transformed lymphoblastoid LCL-HO cell line as a model system of EBV latency and virus-driven B cell proliferation and tumorigenesis. In these cell lines, we further analysed the expression levels for Bmal1 and Per2 via RT-PCR in the course of 24 hours, and these were in agreement with the bioluminescence data ( Fig. S1A,B) .
To investigate the overall presence of circadian oscillating genes in the LCL-HO and the HL cell line HD-MY-Z, we carried out a genome wide time-course array analysis. Out of all genes, 55% (13825) were differentially expressed between both cell lines including a set of genes enriched for the TNF signalling pathway Figure 1 . The network of clock-immune related genes (NCIRG) connects elements of the circadian clock network and the immune system. An enrichment analysis on immune-related GO terms and KEEG pathways of the NCRG, and manual curation based on published data of immune-related genes with interactions with the CCN added a set (35) of immune-related genes (dark blue) to the network. Orange, light green and light purple elements represent the core-clock network (CCN, 20 elements), the extended core-clock network (ECCN) and the network of clock-related genes (NCRG), respectively. Grey lines represent the connection between genes previously published in the NCRG; green and red lines refer to positive and negative (respectively) interactions between newly added immune-related genes and the CCN, based on published data. Black arrows indicate the direction of each interaction. Dashed lines mark the interactions found in modified in vitro/in vivo models. It is important to notice that in some of the studies used for the construction of the network double KD or KO animals/cells were used. In such cases, it was not possible to specify the exact gene responsible for the reported effect on the immune genes, CRY, PER, ROR and REV-ERB were used to refer to the gene family. The direction of the effect is represented by an arrow for activation and a dead end arrow for the inhibition pointing to the affected gene.
SCIenTIFIC RepoRTS | (2018) 8:11474 | DOI:10.1038/s41598-018-29847-z (P = 5.18E-10) ( Fig. S2A -C). Among those, 7402 genes (29%) were downregulated in the HL cell line and 6495 (26%) were upregulated, as compared to the lymphoblastoid B-cells. Our enrichment analysis indicated the predominance of cancer-related pathways within the set of upregulated genes, and immune-related pathways for the set of downregulated genes. Interestingly, the circadian rhythm pathway is enriched in the HL cell line HD-MY-Z, in the set of upregulated genes (P = 0.0117) ( Fig. S2D ,E). The strong upregulation of the circadian rhythm pathway prompt us to analyse the expression levels of the CCN genes for both cell lines in more detail (Fig. 3A) . In particular, the expression levels of Cry1 and Npas2 were strikingly different between the two cell lines (Fig. S1C ). This finding was also confirmed by RT-qPCR, which showed more than a 2-fold increase in the expression of Cry1 and Npas2 in the HL cell line HD-MY-Z as compared to the lymphoblastoid B-cells LCL-HO ( Fig. S1D ). Both Cry1 and Npas2 (a paralog of CLOCK) belong to core-clock components and regulate the negative and positive feedback loops, respectively. They are involved in DNA damage response and cell cycle, and are important for maintaining the correct circadian rhythm of the cells. Next, we searched for commonly/differentially oscillating genes in both cell lines. As expected, the HL cell line HD-MY-Z, which showed a robust circadian clock, had a higher number of oscillating genes than the lymphoblastoid B-cell line LCL-HO (7462 and 1925 oscillating genes respectively, Fig. 3B ). Notably, there were 746 genes oscillating in both cell lines. Both subsets of oscillating genes showed similar enriched pathways, with a predominance of cancer-related terms (Fig. 3C,D) . Tnf oscillated with significant values in both cell lines (LCL-HO, P = 0.003; HD-MY-Z, P = 0.01) as depicted in Fig. 3E and it was also differentially expressed in both cells. TNF signalling was one of the most enriched pathways among the downregulated genes in HD-MY-Z ( Fig. S2D ). This corroborated a role for TNF as a modulator of the circadian clock in our cellular model of a cancer type involving cells of the immune system.
TNF stimulation alters CCN gene expression and cell cycle phase. TNF is a potent pro-inflammatory
cytokine responsible for the regulation of immune cells. This cytokine was also reported as a regulator of genes of the CCN 35, 36 . To gain a deeper understanding of the role of TNF as an elicitor of the core-clock, we stimulated the HL cell lines HD-MY-Z and L-1236 (HL, stage-IV), which showed weaker oscillations compared to 21   21   21   21   22   22   22   22   24   25   25   27   27   29   30   31   32   32   32   32   33   33   34   35   38   43   45 the HD-MY-Z cell line (HL stage-III, Fig. 2F ,G), with TNF for three days and measured gene expression levels of the core-clock genes Bmal1, Per2, Cry1, Cry2, Rev-erbα, as well as Tnf (Fig. 4A ). The stimulations were carried out at a specific time point, but the cells remained in the presence of the stimulating agent during the three days (Materials and Methods) so we no longer had a single time point effect, but a constant effect, as compared to the non-stimulated condition. Our results indicated a general increase in the expression of all core-clock genes in the HL cell line HD-MY-Z upon TNF stimulation, with Per2, Cry1 and Cry2 showing significant changes (P < 0.01, SCIenTIFIC RepoRTS | (2018) 8:11474 | DOI:10.1038/s41598-018-29847-z P < 0.001 and P < 0.05 respectively). In contrast, in the HL cell line L-1236 after a three-day stimulation with TNF there were no changes observed in the mRNA expression levels of the mentioned genes. Additionally, we carried out stimulations with dexamethasone and forskolin, to introduce clock perturbations. Dexamethasone is a known potent anti-inflammatory agent used to treat inflammatory and autoimmune diseases 37 . It is also used in many circadian studies to synchronize cells in culture 38 . Like dexamethasone, forskolin is also used to synchronize the cellular clock 38 and in addition it has a known inhibitory effect on Tnf 39 . Here we stimulated the two HL cell lines, and the lymphoblastoid B-cell LCL-HO with dexamethasone and forskolin for three consecutive days, and evaluated the resulting phenotype in the clock machinery, as well as in Tnf (Figs 4A, and S3A-E, S4A-E). Furthermore, we additionally examined the impact of TNF stimulation on TNF and IL-6 secretion in the three cell lines (Figs 4B, S5). Interleukin-6 (IL-6) is secreted by HL cells, throws in the immunoreactive phenotype and plays a significant pathobiological role in this lymphatic cancer 40 TNF downregulation influences the expression of core-clock elements. We performed shRNA KD in CCN elements and in Tnf to evaluate the output in terms of gene expression, cell proliferation, extracellular concentration of TNF, cell cycle, apoptosis and migration. Upon shBmal1 KD, the HL cell line HD-MY-Z showed a significant increase in the expression of Per2 and Cry2 and a decrease in Rev-erbα, as well as a decrease in Tnf expression ( Fig. 4D ). Additionally, shTnf caused alterations in gene expression of Per2 and Rev-erbα, increasing and decreasing their expression, respectively, in the HL cell line HD-MY-Z, while the KD of Rev-erbα led to an increase in the expression of Bmal1 and Per2 (Figs 4D and S6). Per2 and Rev-erbα silencing exhibit different and specific effects on the expression of core-clock genes in the three cell lines used in this work. In LCL-HO, only Rev-erbα downregulation caused significant alterations in Cry1 and Cry2 increasing their expression, which is in agreement with the known negative regulation of Rev-erbα on Cry expression. In the HL cell lines, we observed an increase in Per2 and Bmal1 expression after Rev-erbα downregulation. Additionally, the KD of Per2 led to an For the HL cell line L-1236, we observed similar results for Rev-erbα gene expression in the shBmal1 cells, but the expression levels of Per2 and Cry2 remained unchanged. In the same cell line, the expression of Cry1 was significantly decreased (Fig. 4D ). The KD of Bmal1 led to cell death in the LCL-HO cell line ( Fig. S3E ). Taken together, these results suggest a major role of TNF in the regulation of several key core-clock genes.
Effects of TNF stimulation on key cellular characteristics of the KD cell lines.
Next, we aimed to explore the stimulatory effects of TNF in the expression of core-clock genes (Bmal1, Per2 and Rev-erbα), as well as in the expression of Tnf in the KD cell lines. The KD cells were stimulated for three days with 50 ng/mL of human recombinant TNF, 0.1 µM of dexamethasone or 25 µM of forskolin. The stimulation of the HL cell line HD-MY-Z with human recombinant TNF triggered an increase in gene expression of the evaluated genes in all the considered experimental conditions ( Fig. 5A) . When compared to the non-stimulated control (non-stimulated, empty vector), the main differences were found in Per2 expression for shBmal1 cells, Tnf expression in shPer2 cells and Bmal1 expression in shRev-erbα cells. Additionally, the downregulation of Tnf caused an increase in Per2 expression and a decrease in Rev-erbα expression. We observed an increase in the expression of Bmal1 and Per2 in shRev-erbα cells. We further observed an increase in the extracellular concentration of TNF for shPer2 and shRev-erbα cells, suggesting an inhibitory effect of Per2 and Rev-erbα on TNF secretion (Fig. 5B ). Furthermore, given the known correlations between IL-6 and TNF expression and also the clock 41, 42 , we aimed to explore whether changes in the expression of TNF in different KD cell lines and after TNF stimulation impacts IL-6 expression (by measuring the IL-6 concentration in the supernatant). An increase of IL-6 concentration was also observed in LCL-HO shRev-erbα cell line ( Fig. S3 ).
We further analysed the impact on the cell cycle caused by perturbations in the core-clock, as well as in Tnf and observed an increase in the percentage of cells in G1 phase and decrease in G2 phase of the cell cycle for the different knockdowns in the HL cell line HD-MY-Z ( Fig. 5C ). We did not observe a significant effect on the cell cycle in shTnf and shRev-erbα cells upon stimulation with TNF, as compared to the observations in the non-stimulated scenario, however, shBmal1 cells acquired a profile closer to the non-stimulated control and the shPer2 cells showed an increase in the G2 cell cycle phase. Despite the similar output in terms of Tnf inhibition, dexamethasone and forskolin did not have similar effects on gene expression of core-clock genes and cell cycle, in the HL cell line HD-MY-Z. Forskolin decreased the Per2 and Cry2 expression in the shBmal1 cells ( Fig. 5A) . In HD-MY-Z-shTnf cells, we observed a decrease in Per2 gene expression and an increase in Tnf, after forskolin treatment. Both dexamethasone and forskolin increased Per2 expression in HD-MY-Z-shPer2-cells, however, forskolin also showed an effect on Bmal1, increasing its expression. In shRev-erbα cells treated with forskolin there was a decrease in Per2 expression. Dexamethasone treatment led to an increase in G2 and decrease in G1 phases in the HL cell line HD-MY-Z as compared to non-stimulated cells, and increased G1 phase in shPer2 and shRev-erbα conditions (Fig. 5C ). Similar to dexamethasone, forskolin also increased G2 and decreased G1 cell cycle phases as compared to non-stimulated cells, however these effects were more prominent. Cell cycle profiles of shTnf and shRev-erbα cells showed alterations after forskolin stimulation, which reverted the effects caused by the shRNA towards a profile similar to the non-stimulated cells (Fig. 5C ). In shPer2 cells, forskolin caused an increase in G2 with a consequent decrease in G1, as compared to the non-treated HD-MY-Z-shPer2. Finally, we examined the impact of the different knockdowns on cell proliferation, for the HL cell line HD-MY-Z (Fig. 5D ). Compared to the pLKO.1 (empty vector), shPer2 cells showed increased proliferation, whereas shBmal1 and shTnf dramatically reduced proliferation (Fig. 5D ).
Dysregulation of the circadian clock impacts HL cell migration and apoptosis.
We further analysed the influence of circadian clock dysregulation in the HL cell line HD-MY-Z regarding apoptosis and migration. Our data showed a remarkable decrease in apoptosis in shPer2 and shTnf HD-MY-Z-cells and an increase of apoptosis in the shRev-erbα cells (Fig. 5E ). To investigate the role of TNF in apoptosis, we stimulated all KD cell lines with TNF and measured their apoptotic rate. Upon TNF stimulation, we observed a general increase in the apoptosis rate of shRev-erbα-, shTNF-and shBmal1-HD-MY-Z cells, corroborating a tumour suppressing role for TNF ( Fig. 5F ). Interestingly, shPer2 cells exhibited a greater decrease in apoptosis compared to the non-stimulating scenario (Fig. 5E,F) . This points to an inhibitory effect of TNF on Per2 expression resulting in reduced apoptosis.
We additionaly explored the impact of the different perturbations in the migratory properties of the HL cell line. Cell migration was determined by measuring the wound confluence over 34 hours (Fig. 6A,B) . Among all KD cell lines, shRev-erbα showed the highest migration activity when compared to the empty vector control cells, suggesting that suppression of Rev-erbα expression had a positive effect on the migration properties of the HL cell line HD-MY-Z. In contrast, shTnf and shBmal1 cell lines showed decreased migration when compared to the empty vector control cells. These results indicate that CCN genes, as well as TNF are involved in key cellular properties of HL cells, and their influence in cell proliferation and migration may play a role in HL progression.
Discussion
The circadian clock machinery generates rhythmic patterns in the expression of genes and proteins that allow physiological and cellular functions to be fine-tuned and coordinated in time. These are crucial for the timely segregation of incompatible cellular processes and for energy conservation purposes. This preserved rhythmicity characterizes also the function and components of the immune system, and ensures the conservation of body homeostasis and defence mechanism. Several studies point to a bidirectional crosstalk between the circadian pathway and the immune system, and characterize the effects of inflammation and cytokines on circadian rhythms 43, 44 .
In this study, we further investigated the extent of such a bidirectional communication in a lymphatic cancer and validated different interacting partners of both systems by generating a comprehensive network of clock-immune related genes (NCIRG) which highlighted a major potential bridging element, TNF. To examine this interplay, we first carried out an enrichment analyses for circadian rhythm related genes in different cancers and found Hodgkin lymphoma to have a significant differential expression for genes of the circadian rhythm pathway.
From the analysis of high-throughput time-course data for a stage-III HL cell line (HD-MY-Z) and by comparing these results with the lymphoblastoid-B cell line, LCL-HO, which exhibits weak oscillations in the expression of core-clock genes, we determined the number of oscillating genes in both cell lines and found a strong link between the oscillating genes and cancer-related pathways, in particular for the HL cell line HD-MY-Z. Since we identified more robust circadian oscillations and a larger number of oscillating genes in the HL cell line HD-MY-Z with respect to the LCL-HO cell line, we suggest that a properly functioning circadian clock machinery might be necessary for HD-MY-Z cell survival and malignant phenotype. Tnf is a well-known immune system gene. Its expression is controlled by the core-clock network via the D-box elements found in its promoter region 45 . TNF and its receptors (TNFR1 and TNFR2) fulfil several functions, namely the crucial control of lymphocyte expansion and preservation of their structural integrity, and function as well as immunocompetent cells in the development of immune responses. TNF seems to act as a bridging element between the core-clock and the immune system, as also shown by our data. TNF modulates the immune system function through the down-regulation of T-cell receptor (TCR) signalling, calcium flux changes, p21, p23 and ZAP70 activation, and reduced NF-κB nuclear activation 41 . Conversely, the biological clock directly controls the production of important cytokines: in particular CRY1 and CRY2 suppress the expression of the genes encoding TNFα and IL-6, and REV-ERBα restrains the induction of IL-6. In turn, these cytokines impact the functioning of the biological clock 42 . IL-6 levels are augmented in patients with Hodgkin lymphoma and are correlated with a poor prognosis. Also in our study we measured an increase of IL-6 in the HL stage-IV cell line L-1236, as compared to the stage-III cell line HD-MY-Z. Furthermore, IL-6 and other cytokines are produced in HL by Reed-Sternberg cells or infiltrating reactive cells, comprising lymphocytes, plasma cells, eosinophils and histiocytes, and might contribute to the impairment of immune response and to leukocyte trafficking, preserving a supporting environment for RS cells survival. IL-6 acts in an autocrine or paracrine way supporting a tumour environment that allows for Reed-Sternberg cells survival and proliferation by hindering apoptosis and host anti-tumour defence, which is likely to trigger weight loss, night sweats, fever, and other paraneoplastic reported symptoms 46 . The appropriate modulation of IL-6 dependent pathways may consent to expand the targeted approaches in HL therapy 47 . In our experiments, we inspected the oscillating pattern of Tnf expression in the HL cell line HD-MY-Z and the lymphoblastoid-B cells LCL-HO and investigated the role of TNF stimulation at the molecular and cellular levels in WT and knock-down variants of HD-MY-Z. Upon TNF stimulation, we observe a general increase in the expression levels of core-clock elements, among them Bmal1, Per2 and Rev-Erbα. This finding is consistent with previous studies in rheumatoid synovial cells 36 and in fibroblasts at early time points 48 which point to elevated expression of the mentioned genes upon TNF stimulation. Following gene knock-down, we measured gene-specific effects of TNF on the core-clock elements. In particular, Per2 expression appears to be negatively controlled by TNF. While the expression of Per2 was significantly increased in shTnf cells, Tnf expression was increased dramatically in shPer2 cells. This inhibition could be due to E-box-mediated interfering effects of TNF on Per2 transcription as previously reported 49 . In patients with metastatic colorectal cancer statistically significant correlations were found between pre-treatment levels of cytokines, circadian patterns in wrist activity and serum cortisol and tumour-related symptoms. In particular, patients with reduced 24-hour rest/activity patterns quantified by actigraphy showed significantly higher serum levels of TGF-α, TNF-α and IL-6 17 . Similarly, in our study we observe higher levels of TNF-α for the two cell lines which have the less robust clock (LCL-HO and the HL cell line L-1236, Fig. S5 ) further strengthening the previously described correlation between the clock phenotype and alterations in immune elements, in a cancer context.
Our results further indicate a role for TNF as an enhancer of proliferation leading to an increased amount of cells in the S-phase in HD-MY-Z cells (Fig. 6C ) which can be achieved via the activation of the NF-kB pathway. Interestingly, we did not find significant effects of TNF stimulation in the cell cycle for LCL-HO and L-1236 cell lines indicating its specific role in cell lines which are hallmarked by proper oscillations of clock genes. As such, the loss of a functional clock in the L-1236 seems to affect the feedback from the TNF to the core-clock clock (upon perturbation of TNF the expression levels of the clock genes is rather constant), and to result in a larger S-phase, as observed for these cells. Interestingly, in non-Hodgkin lymphoma patients circadian rhythms in S-G2-M cell cycle phases were shown in malignant lymph nodes of stage IIIB (p = 0.046 for 24-h cosine fit), but not stage IV (p = 0.560 for 24-h cosine fit) disease 16 . Even though this is a different model (non-Hodgkin lymphoma) as compared to the one used in our work (Hodgkin lymphoma), we observed as well a loss of robustness in circadian rhythms for the stage IV cell lines. This could indeed impact the cell cycle given the strong interconnection between the cell cycle and the circadian clock oscillators, as shown by our own work and others 14, 50 .
Altogether, our results obtained from KD cell lines, point to a role of TNF in regulating the cell cycle for HD-MY-Z KD cells, and its ability to restore altered cell cycle phases in KD cells. Our results from the proliferation analysis data identified Per2 as a potential proliferation inhibitor, while Bmal1 and Tnf acted as enhancers of cell proliferation in the HL cell line HD-MY-Z. This could result from the negative regulatory role of PER2 in the clock machinery and the positive effects of BMAL1 and TNF in enhancing the transcription of clock-controlled genes involved in proliferation. Importantly, Bmal1 and Per2 may impact cellular physiology in different ways. Either influencing the clock machinery and altering circadian rhythms, and/or by influencing the expression of genes that are direct targets of CLOCK/BMAL1 and/or of PER2. This could be a result of other potential, non-circadian, functions of Bmal1 and Per2. To differentiate between these two hypotheses and to better characterize the specific output results of Bmal1 and Per2 knock-down phenotypes further studies are necessary.
Cell apoptosis was dramatically influenced and decreased in shPer2 cells upon TNF stimulation (Fig. 6C ), which can be correlated with the inhibitory effects of TNF on Per2. Since TNF represses Per2 expression, this could lead to a decreased expression of Bmal1 resulting in reduced CLOCK/BMAL1 levels and eventually derepression of c-Myc followed by reduced apoptosis, as previously reported 51 . The migratory properties of the HL HD-MY-Z KD cell lines reveals a role for Rev-Erbα as a motility suppressor. These findings corroborate the results of experiments performed in an acute myeloid leukaemia mouse model showing that leukaemia stem cells are dependent on a functioning biological clock. Derangement of the molecular clockwork induces weakened proliferation, superior myeloid differentiation, and leukaemia stem cells exhaustion, with resulting overall anti-leukemic effects 52 . It would be interesting in future work to validate our results in an in vivo model (mouse, humans). However, this goes beyond the scope of this study that we consider exploratory in this first phase.
The interplay between the circadian and the immune systems highlighted by our bioinformatics analyses and corroborated by our experimental procedures performed in lymphoma cells pinpointed a crucial role played by this bidirectional interaction in determining cancer cell phenotype. According to our results, a deregulated biological clock impacts on proliferation, migration and cell death in HL cell lines. Differently from what has been observed for solid cancers, a well-running molecular clockwork ticks in medium stage lymphoma cells and supports malignancy, whereas its perturbation hinders malignant phenotype maintenance and it seems to be altered in more advanced lymphoma stages. Hodgkin lymphoma, as well as other lymphoma types, is not representative of the whole immune system, considering the monoclonality hallmarking cancer beyond intratumour heterogeneity in comparison to the multiclonality of the majority of immune components, and the genomic and phenotypic alterations of a cancer respect to the normal tissue. As such, additional model systems such as T-cell lymphoma, leukaemia and multiple myeloma should be considered in future work, to further extend the findings here reported to cancers of the immune system. Key players in the aforementioned interplay could be represented by small molecules, in particular cytokines such as TNF and IL-6, whose secretion is circadian regulated, and which have been shown capable to impact the functioning of the biological clock. In our study we focused on TNF, a major inflammatory cytokine originally documented as capable to provoke, in experimental cancers, haemorrhagic necrosis, but subsequently found to paradoxical act as a tumour-promoter. Our results corroborate its role as a key intermediary of the circadian -immune network, impacting the expression of core-clock genes and inducing phenotypic changes in lymphoma cells. The findings of our experimental approach may also contribute to advance our knowledge of the physiopathological mechanisms bringing on malignancy in lymphoma cells with the aim to identify key molecules and valuable compounds for potential targeted therapeutic strategies. Even though we did not explore the usage of therapeutics associated to the circadian system 53 in this work, there are potential implications of our findings in the clinic which justify future work. Cell-autonomous molecular clockworks may play a significant role in lymphoid malignancies treatment impacting lymphatic cancer cells phenotype and in particular cell growth and proliferation, by driving oscillations of cell-cycle genes important for the G1-to-S transition. The cell division cycle is under circadian control and restoring clock function in lymphatic cancer cells harbouring a dysfunctional molecular clockwork could slow down their growth. In contrast, clock-interfering treatments such as inhibition of the cancer clock by shRNA-mediated knock-down, could significantly decrease proliferation and tumour growth in lymphatic cancer cells hallmarked by rhythmic clock gene expression. Characterization of the subjective patterns of oscillatory gene expression could orientate tailored therapy of lymphoma patients in the setting of personalized medicine. Furthermore, the investigation of the circadian control over the cell cycle through small molecules impacting the biological clock could lead to the modulation of lymphatic cancer cells proliferation and support anticancer effects of chemotherapy and surgical tumour resection. 
Methods
Network of clock-immune related genes. The network construction involved two different approaches.
In the first approach, an enrichment analysis of the previously published network -NCRG 4 was carried out using DAVID Bioinformatics Resources 6.8 54 . Genes containing immune-related associations were selected for the present network. Interactions from the previous network were maintained and are represented in grey. Text mining was performed with the Agilent Literature Search plugin for Cytoscape using the Pubmed database. The second approach involved manual curation of published experimental data. Positive and negative interactions are represented in green and red, respectively. Network visualization was generated using Cytoscape version 3.4 55 . A list of new interactions can be found in Table S1 .
Cancer Cell Line Encyclopaedia (CCLE) analysis. Cancer Cell Line Encyclopaedia (CCLE) contains expression data from 947 cancer cell lines performed using Affymetrix GeneChip Human Genome U133 Plus 2.0 Array. A total of 174 cell lines were included in the CCLE tumour type group 2 (haematopoietic) and grouped into 10 different groups: acute myeloid leukaemia (AML, n = 33), B cell acute lymphoblastic leukaemia (B-cell ALL, n = 12), chronic myeloid leukaemia (CML, n = 14), T-cell acute lymphoblastic leukaemia (T-cell ALL, n = 14), others_leukaemia (n = 5), Burkitt's lymphoma (n = 10), diffuse large B cell lymphoma (DLBCL, n = 16), Hodgkin lymphoma (HL, n = 13), others_lymphoma (n = 28) and multiple myeloma (n = 27). Robust Multi-array Average (RMA) normalisation was performed by the Expression Console (EC (Affymetrix)) and Gene level differential expressed analysis were performed by Transcriptome Analysis Console v3.0 (TAC (Affymetrix)). One-Way Between-Subject ANOVA (unpaired) algorithm was used to detect differential expressed genes (filter criteria: Fold Change (linear) <−2 or >2 and ANOVA p-value (condition pair) <0.05). Heatmaps were generated using ComplexHeatmap software package 56 HD-MY-Z, LCL-HO and L-1236 (Hodgkin lymphoma, stage IV, refractory, terminal, third relapse) cell lines were maintained in RPMI 1640 (Gibco) supplemented with 1% penicillin-streptomycin (Gibco) and 10% foetal bovine serum (Gibco). Stable-transduced cells were selected and maintained in medium containing 100 μg/ mL hygromicin B (Gibco) for the Bmal1:luc hygromicin (BLH), 10 μg/mL of blasticidin S HCl (Gibco) for the Per2:luc blasticidin (PLB) and 10 μg/mL of puromycin for the shRNA KD of the clock genes and Tnf. For live-cell bioluminescence recording (evaluation/analysis/monitoring), cells were maintained in phenol red-free RPMI 1640 (Gibco) containing 10% foetal bovine serum, 1% penicillin-streptomycin and 0.1 mM D-Luciferin (PJK). For cell stimulation, cells were maintained for 3 days in medium (RPMI 1640 (Gibco) supplemented with 1% penicillin-streptomycin (Gibco) and 10% foetal bovine serum (Gibco)) with 50 ng/mL of human recombinant TNF (BioLegend), or 0.1 µM of Dexamethasone (Sigma-Aldrich) or 25 µM of Forskolin (Sigma-Aldrich) as previously described [58] [59] [60] [61] [62] . Cell morphology and concentration were analysed in LUNA ™ Automated Cell Counter (Logos Biosystems). All cells were incubated at 37 °C with 5% CO 2 atmosphere. All three cell lines express glucocorticoid, TNF and cathecolamine receptors as previously reported 63, 64 and as also fund in our array data.
Lentivirus production. Lentiviral elements containing a BMAL1-promoter-driven luciferase (BLH), a PER2-promoter-driver luciferase (PLB), an empty vector (TRC Lentiviral pLKO.1 Empty Vector Control Dharmacon Inc., Lafayette, CO) or a shRNA KD (TRC Lentiviral Human ARNTL shRNA -Clone ID: TRCN0000019097; TRC Lentiviral Human TNF shRNA -Clone ID: TRCN0000003758; TRC Lentiviral Human PER2 shRNA -Clone ID: TRCN0000018541;TRC Lentiviral Human NR1D1 shRNA -Clone ID: TRCN0000022176 (Dharmacon Inc., Lafayette, CO)) were used in the present work. HEK293T (human, kidney, ATCC Number: CRL-11268) cells were seeded in 175 cm 2 culture flasks and co-transfected with 12.5 µg packaging plasmid psPAX, 7.5 µg envelope plasmid pMD2G and 17.5 µg BLH,PLB or shRNA KD expression plasmid using the CalPhos mammalian transfection kit (Clontech) according to the manufacturer's instruction. To harvest the lentiviral particles, the supernatant was centrifuged at 4100 × g for 15 min to remove cell debris and passed through a 45 µm filter. Lentivirus were stored at −80 °C.
Transduction with lentiviral vectors. 1 × 10 6 cells were seeded in a 6-well plate with 1 mL of RPMI1640, 10% foetal bovine serum, 1% penicillin-streptomycin and 4 µg/mL Polybrene (Sigma). 1 mL of supernatant of the corresponding lentivirus were added to each well and plates were centrifuged for 90 min at 34 °C at 1000 g. Supernatant was discarded after 4 hours incubation at 37 °C with 5% CO 2 and 2 mL of fresh medium was added. Two days after, the medium was replaced by selection medium (supplemented with hygromicin S, basticidin S HCl or puromycin (according to the lentivirus construct used)) and incubated at 37 °C with 5% CO 2 atmosphere. Cells were maintained in selection medium for at least two weeks. For the shRNA KD, the KD efficiency was determined by gene expression analysis.
Synchronization and measurement of circadian rhythms. For bioluminescence measurement, 0.5-1 × 10 6 cells were washed once with 1× PBS, plated in 35 mm dishes and synchronized by adding fresh SCIenTIFIC RepoRTS | (2018) 8:11474 | DOI:10.1038/s41598-018-29847-z phenol-red-free RPMI 1640 medium supplemented with 10% foetal bovine serum, 1% penicillin-streptomycin and 0.1 mM D-Luciferin. Bmal1-promoter-(BLH)-reporter or Per2-promoter-(PLB)-reporter activities were measured, using the LumiCycle instrument (Actimetrics). After bioluminescence recording for 5-7 days, phase, period and amplitude were analysed with the ChronoStar analysis software V3.0 using 24 h running average de-trended method and fitting cosines curves were calculated as output 65 .
RNA isolation and cDNA synthesis. Cells were seeded in 35 mm dishes with a density of 5 × 10 5 cells/ dish and synchronized by fresh medium addition. Cells were collected every three hours, in triplicates and the pellets were stored at −80 °C. Total RNA was isolated using the RNeasy extraction kit (Qiagen), including DNase digestion, according to the manufacturer's instructions. Cells were lysed with 350 µl RLT buffer and the lysate was homogenized. Total RNA concentration was determined using NanoDrop® ND-1000 UV-Vis Spectrophotometer and stored at −80 °C. 1 µg of total RNA was reverse-transcribed to cDNA with M-MLV reverse transcriptase (Invitrogen), random hexamers (Eurofins MWG Operon) and dNTPs Mix (Thermo Fisher).
Quantitative real-time PCR. For gene expression quantification, we used SYBR-Green (Bio-Rad Laboratories, Hercules, CA) based real-time PCR in 96-well plates and the human commercial primers from QuantiTect primer assays (Qiagen) for Gapdh (housekeeping gene), Bmal1, Per2, Tnf, Cry1, Cry2 and Rev-erbα. The reaction was performed in a real-time PCR Detection System (Bio-Rad). Each sample was measured in duplicates and the C T values were determined by using the regression method. The expression levels were normalized to those of Gapdh (ΔCT) and calibrated to the mean expression value of each gene (time-course analysis) or in relation to the respective control. (ΔΔC T ). The relative quantification was performed using the 2 −ΔΔCT method.
Microarray analysis. Microarray analysis was performed in R version 3.4.2 using the oligo package.
Multi-Array Average (RMA) pre-processing procedure was used to normalise expression levels of genes 66 . HTA 2.0 were annotated by merging data with probeset annotations provided online (www.affymetrix.com). Heatmaps were generated using ComplexHeatmap software package 56 for statistical programming environment R. The R package arrayQualityMetric 67 was used for quality control and statistical testing of the arrays.
The microarray dataset has been deposited in the ArrayExpress database at EMBL-EBI (www.ebi.ac.uk/ arrayexpress) under the accession number E-MTAB-6400 and will be released upon publication. Differentially expressed genes were determined with the limma package 68 . Normalization of the arrays was done for both cell lines together using RMA, the additional normalization of array data was done with the BBmisc R package in the range −1, 1. The MetaCycle R package was used to determine the oscillating genes with the three built-in methods ARS, JTK and LS. The period was set to 21-27 h. Only genes with a Metacycle combined p-value lower than 0.05 were used for further analysis. Enrichment analysis. The analysis in enriched pathways was performed using the KEGG data base. Enrichment analysis were performed in an open access online platform, DAVID Bioinformatics Resources 6.8 54 using the default settings.
ELISA.
To detect the supernatant concentrations of TNF and IL-6, a "sandwich" enzyme-linked immunosorbent assay (ELISA) was performed using the Human TNF-α ELISA MAX™ Deluxe and Human IL-6 ELISA MAX™ Deluxe (Biolegend, San Diego, CA), respectively, according with the manufactorer's instructions. Plates' absorbance was read at 450 nm in VICTOR light 1420 (Perkin Elmer, Waltham, MA).
Cell cycle measurements. Cells used for cell cycle studies were washed with 1X PBS and fixed with ice-cold 80% ethanol. After fixation, cells were washed, resuspended in 150 µL of 1X PBS and stained for 30 min with 150 µL of a solution containing 0.05 mg/mL of PI (Sigma-Aldrich), 0.3% triton x-100 (Sigma-Aldrich) and 10 mg/ mL of RNase (AppliChem GmbH, Darmstadt, Germany) in 1X PBS. Samples were read in FACSCabilur (Becton Dickinson, Franklin Lakes, NJ). The cells of interest were gated based on forward scatter/side scatter (FSC versus SSC) values. The cell cycle analysis was handled by fitting a univariate cell cycle model to the gated population using the Dean-Jett Fox 69 option, implemented in FlowJo v10.2 (FlowJo, LLC, Ashland, OR). Proliferation, apoptosis, and migration measurements. Proliferation assays. For the proliferation assay, 2500 cells/well were seeded in a 96-well plate (Eppendorf). Cell were allowed to adhere and placed in the IncuCyte® S3 Live Cell System Analysis (Essen BioScience). Four pictures were recorded every hour for the 3 biological replicates and 4 technical replicates. Analysis were performed using the IncuCyte S3 Software (Essen BioScience).
Apoptosis assays. HD-MY-Z KD cell lines (shBmal1, shPer2, shRev-erbα and shTnf) as well as WT cells were seeded in 6-well plates containing RPMI 1640 (Gibco) supplemented with 1% penicillin-streptomycin (Gibco) and 10% foetal bovine serum (Gibco). At around 80% confluency cells were washed once with 1x PBS (Gibco) and counted using a Luna Automated Cell Counter. Cells were seeded in a 96-well plate (Eppendorf) at a concentration of 2500 cells/100 µL medium and incubated for 24 hours at 37 °C with 5% CO 2 . For each cell line three biological replicates and four technical replicates were prepared. After 24 hours incubation, cell media were replaced with fresh medium containing caspase 3/7 (1:2000) and TNF (50 ng/mL) (only for the TNF stimulation experiment). Cell apoptosis was measured using the IncuCyte® S3 Live Cell System Analysis. Cells were scanned every 3 hours with a 10x objective and by using the phase and green image channels. Apoptosis data were normalized with the proliferation data for each cell line. Migration assays. For the migration assay, 35000 cells/well were seeded in a 96-well Essen ImageLock TM microplate (Essen BioScience) and incubated overnight at 37 °C, 5% CO 2 . In the next day, the WoundMaker TM (Essen BioScience) was used to create precise and reproducible wounds. The medium was replaced with fresh medium and the plate was placed in the IncuCyte ® S3 Live Cell System Analysis (Essen BioScience). Image acquisition was performed by setting the "scan type" to Scratch Wound and Wide Mode, using the 10x objective. The plate was scanned every hour. Analysis was performed with the scratch wound method in the IncuCyte S3 Software (Essen BioScience).
Statistical Analysis.
The experiments were carried out with at least three biological replicates for each condition. All results are represented as mean ± SEM. Statistical analysis was performed using two-tailed unpaired t-test. A p-value < 0.05 was considered as statistical significant. (*p < 0.05; **p < 0.01; ***p < 0.001).
